//fpnotebook.com/
Oxcarbazepine
Aka: Oxcarbazepine, Trileptal- Indications
- Adverse Effects: Dose related
- Adverse Effects: Other
- Dosing
- Child (age 4 to 16 years old)
- Initial: 8-10 mg/kg/day divided twice daily
- May be increased by 5 mg/kg/day up to every 3 days, up to maximum dose
- Adult (includes elderly)
- Initial: 300 mg (max 600 mg) orally twice daily
- Increase by 300 mg/day each week
- Child (age 4 to 16 years old)
- References
Medication Costs | ||
---|---|---|
oxcarbazepine (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
OXCARBAZEPINE 150 MG TABLET | Generic | $0.14 each |
OXCARBAZEPINE 300 MG TABLET | Generic | $0.17 each |
OXCARBAZEPINE 300 MG/5 ML SUSP | Generic | $0.44 per ml |
OXCARBAZEPINE 600 MG TABLET | Generic | $0.35 each |
trileptal (on 2/22/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
TRILEPTAL 150 MG TABLET | Generic | $0.14 each |
TRILEPTAL 300 MG TABLET | Generic | $0.17 each |
TRILEPTAL 300 MG/5 ML SUSP | Generic | $0.44 per ml |
TRILEPTAL 600 MG TABLET | Generic | $0.35 each |
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. |
oxcarbazepine (C0069751) |
|
---|---|
Definition (NCI) | A dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepine is converted to its active metabolite, 10-monohydroxy. Although the mechanism of action has not been fully elucidated, electrophysiological studies indicate this agent blocks voltage-gated sodium channels, thereby stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing the propagation of synaptic impulses. |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | C036006 |
SnomedCT | 323042005, 116511002, 387025007 |
LNC | LP20805-5, MTHU012038 |
English | 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide, oxcarbazepine (medication), OXCARBAZEPINE, oxcarbazepine [Chemical/Ingredient], oxcarbazepine substance, OXcarbazepine, oxcarbazepine, Oxcarbazepine (product), Oxcarbazepine (substance), Oxcarbazepine |
Spanish | oxcarbacepina, oxcarbazepina (producto), oxcarbazepina (sustancia), oxcarbazepina |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Trileptal (C0876196) |
|
---|---|
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | C036006 |
English | trileptal, Novartis brand of oxcarbazepine, Trileptal |
Japanese | オクスカルバゼピン |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.